Market Overview

FusionPharm Intends to Liquidate and Dissolve Company

Share:



FusionPharm Intends to Liquidate and Dissolve Company

FusionPharm Intends to Liquidate and Dissolve Company

LAKEWOOD, CO--(Marketwired - May 3, 2017) - FusionPharm, Inc., (OTC PINK: FSPM), a company engaged in the development, sale and distribution of the patent pending PharmPods advanced hydroponic cultivation system is liquidating in expectation of dissolving the Company.

Pending legal proceedings have made it impossible for the Company to continue operations. Scott Dittman, the Company's remaining sole officer and director, has stepped down from these positions after authorizing the Company's legal counsel to handle the liquidation.

Safe Harbor Statement

This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with OTC Markets.

For Additional Information Contact:

Andrew Telsey, Esq,

andrew@telseylaw.com


View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com